EcoDrugPlus

Ensembl ID : WBGene00004471
Gene Symbol: WBGENE00004471
7 External references
128 Possible Orthologues:

Ensembl ID : WBGene00004472
Gene Symbol: WBGENE00004472
7 External references
206 Possible Orthologues:

Ensembl ID : WBGene00004473
Gene Symbol: WBGENE00004473
7 External references
125 Possible Orthologues:

Ensembl ID : WBGene00004474
Gene Symbol: WBGENE00004474
7 External references
117 Possible Orthologues:

Ensembl ID : WBGene00004475
Gene Symbol: WBGENE00004475
7 External references
114 Possible Orthologues:

Ensembl ID : WBGene00004476
Gene Symbol: WBGENE00004476
7 External references
92 Possible Orthologues:

Ensembl ID : WBGene00004477
Gene Symbol: WBGENE00004477
7 External references
115 Possible Orthologues:

Ensembl ID : WBGene00004492
Gene Symbol: WBGENE00004492
7 External references
118 Possible Orthologues:

Ensembl ID : WBGene00004493
Gene Symbol: WBGENE00004493
7 External references
91 Possible Orthologues:

Ensembl ID : WBGene00004494
Gene Symbol: WBGENE00004494
7 External references
89 Possible Orthologues:

Ensembl ID : WBGene00004495
Gene Symbol: WBGENE00004495
7 External references
98 Possible Orthologues:

Ensembl ID : WBGene00000408
Gene Symbol: WBGENE00000408
7 External references
73 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).